<DOC>
	<DOCNO>NCT02276313</DOCNO>
	<brief_summary>BIOLUX P-III prospective , international , multi-centre , postmarket all-comers registry collect clinical performance data Passeo-18 Lux paclitaxel release balloon catheter treatment atherosclerotic disease infrainguinal artery .</brief_summary>
	<brief_title>BIOLUX P-III All-Comers Passeo-18 Lux Registry</brief_title>
	<detailed_description>The Passeo-18 LUX Paclitaxel Releasing BalloonCatheter novel drug-releasing balloon receive CE-mark January 2014 . Its safety efficacy investigate two randomized First-in-Man trial patient stenosis occlusion femoropopliteal ( BIOLUX P-I ) infrapopliteal ( BIOLUX P-II ) artery compare uncoated device . The purpose BIOLUX P-III all-comers registry collect short long-term clinical performance data Passeo-18 Lux DRB treatment atherosclerotic disease infrainguinal artery all-comers patient population daily clinical practice .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Age ≥ 18 year minimum age require local regulation Subject must willing sign Patient Data Release Form Patient Informed Consent applicable Lesion ( ) infrainguinal artery suitable endovascular treatment treat schedule treated Passeo18 Lux drug release balloon Life expectancy ≤ 1 year Subject currently participate another investigational drug device study reach ist primary endpoint yet Subject pregnant planning become pregnant course study Failure successfully cross target lesion guide wire ( successful crossing mean tip guide wire distal target lesion absence flow limit dissection perforation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Peripheral</keyword>
	<keyword>Infrainguinal</keyword>
	<keyword>Drug Releasing Balloon</keyword>
	<keyword>Drug Eluting Balloon</keyword>
</DOC>